Find in Library

The impact of disagreement between prognostic risk scores on oncologic outcomes of metastatic renal cell carcinoma (mRCC) patients in the tyrosine-kinase inhibitor (TKI) era

oleh: F. Janisch, P. Marks, C.P. Meyer, H. Yu, C. Fühner, R. Dahlem, M. Abufaraj, S.F. Shariat, M. Fisch, M. Rink